Legal & General Group PLC Legend Biotech Corp Transaction History
Legal & General Group PLC
- $368 Billion
- Q4 2024
A detailed history of Legal & General Group PLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Legal & General Group PLC holds 299,775 shares of LEGN stock, worth $11.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
299,775
Previous 493,731
39.28%
Holding current value
$11.5 Million
Previous $24.1 Million
59.46%
% of portfolio
0.0%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding LEGN
# of Institutions
230Shares Held
86MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$287 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$260 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$229 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$219 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$218 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.4B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...